Loading
₹908.00
+5.50+0.61%today
Market closed · 7 Oct, 3:30 pm
−19.70%over 1 year
Today's range
₹891.60₹911.25
52-week range
₹891.60₹1,221.90
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 8,225 | 1,442 | 17.5% | 14.76 |
| FY25 | 6,910 | 1,076 | 15.6% | 11.01 |
| FY24 | 5,309 | 1,058 | 19.9% | 10.84 |
| FY23 | 4,489 | 1,104 | 24.6% | 11.36 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 23.71% | 23.71% | 23.72% | 23.74% |
| FIIs | 41.78% | 45.39% | 50.55% | 51.80% |
| DIIs | 29.96% | 26.32% | 21.20% | 20.03% |
| of which mutual funds | 18.68% | 16.30% | 14.04% | 14.25% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 4.56% | 4.57% | 4.52% | 4.43% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND | 2,500.00 | 0.00% | 1,03,261 |
| Dr. Reddy's Laboratories Ltd.DRREDDY | 1,203.80 | −0.35% | 1,00,476 |
| Aurobindo Pharma Ltd.AUROPHARMA | 1,682.00 | −0.64% | 96,779 |
| Lupin Ltd.LUPIN | 2,012.90 | −0.81% | 92,048 |
| Max Healthcare Institute Ltd.MAXHEALTH · this stock | 908.00 | +0.61% | 88,377 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.